| Treatment administered | Treatment dose | |||||
|---|---|---|---|---|---|---|
| Agent | CFA n (%) | Control n (%) | p valuea |
CFA Median (IQR) Mean |
Control Median (IQR) Mean | P valueb |
| Electricity (Joules) | 205 (46%) | 211 (47%) | 0.69 |
600 (400–800) 623.7 |
600 (400–800) 623.7 | 0.93 |
| Epinephrine (mg) | 450 (100%) | 450 (100%) | 1.0 |
5 (4–6) 4.95 |
5 (4–6) 5 | 0.52 |
| Vasopressin | 222 (49%) | 213 (47%) | 0.55 |
40 (40–40) 40 |
40 (40–40) 40 | 1.0 |
| Atropine (mg) | 110 (24%) | 103 (23%) | 0.58 |
1 (0.5–1) 0.78 |
1 (0.5–1) 0.77 | 0.60 |
| Lidocaine (mg) | 145 (32) | 146 (32%) | 0.94 |
200 (160–200) 176.8 |
200 (150–200) 172.3 | 0.32 |
| Amiodarone (mg) | 185 (41%) | 195 (43%) | 0.50 |
450 (300–450) 386.8 |
450 (300–450) 390.8 | 0.60 |
| Sodium bicarbonate (mEq) | 146 (32%) | 155 (34%) | 0.52 |
89.2 (66.9–133.8) 99.4 |
89.2 (66.9–133.8) 105.3 | 0.30 |